Ensysce Biosciences (ENSCW) Equity Average (2018 - 2025)
Ensysce Biosciences (ENSCW) reported Equity Average of $2.0 million for Q4 2025, down 58.95% year-over-year from $5.0 million in Q4 2024, and down 4.12% quarter-over-quarter from $2.1 million in Q3 2025.
Ensysce Biosciences (ENSCW) Equity Average (2018 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 8 years of Equity Average data on file, last reported at $2.0 million in Q4 2025.
- Equity Average for Q4 2025 came in at $2.0 million, down 58.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.0 million (down 58.95% YoY), and the FY2025 annual result was $3.1 million, up 129.59% from the prior year.
- Equity Average fell to $2.0 million in Q4 2025 per ENSCW's latest filing, from $2.1 million in the prior quarter.
- Over five years, Equity Average peaked at $5.0 million in Q4 2024 and troughed at -$7.0 million in Q1 2021.
- A 5-year average of $164327.3 and a median of $1.6 million in 2023 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2024: Equity Average sank 250.97% in 2022, then jumped 1866.73% in 2024.
- A 5-year view of Equity Average shows it stood at -$4.3 million in 2021, then fell by 22.34% to -$5.2 million in 2022, then jumped by 104.85% to $253204.0 in 2023, then jumped by 1866.73% to $5.0 million in 2024, then slumped by 58.95% to $2.0 million in 2025.
- Business Quant data shows ENSCW's Equity Average at $2.0 million in Q4 2025, $2.1 million in Q3 2025, and $2.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Ensysce Biosciences | - | - | - | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 253,204.00 |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | -2.09 Mn |
| Dec 31, 2022 | -5.23 Mn |
| Sep 30, 2022 | -3.61 Mn |
| Jun 30, 2022 | 156,847.50 |
| Mar 31, 2022 | -3.52 Mn |
| Dec 31, 2021 | -4.27 Mn |
| Sep 30, 2021 | 2.39 Mn |
| Jun 30, 2021 | -1.07 Mn |
| Mar 31, 2021 | -6.98 Mn |